~10 spots leftby Jun 2025

Contingency Management for Smoking Cessation

Recruiting in Palo Alto (17 mi)
BT
Overseen byBenjamin Toll, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Medical University of South Carolina
Must be taking: Nicotine patch
Disqualifiers: Unstable psychiatric, Non-English, Pregnant, others
No Placebo Group
Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?

This is a smoking cessation treatment study. Patients who have a cancer or a suspected cancer who will undergo surgical removal of their cancer are eligible to participate in this study. A novel smoking cessation treatment will be provided to half of the participants in the study. All study participants will receive standard smoking cessation therapy including counseling and the nicotine patch.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Contingency Management for smoking cessation?

Research shows that using financial incentives, like prizes or vouchers, can help people quit smoking by rewarding them for not smoking. Studies found that people are more likely to stop smoking when they receive rewards for staying smoke-free, and this approach has been effective in various settings, including with pregnant women and socioeconomically disadvantaged individuals.12345

Is contingency management for smoking cessation safe for humans?

Contingency management, which includes methods like prize-based incentives, has been used safely in various settings, including with pregnant women and socioeconomically disadvantaged adults, without reported safety concerns.12678

How does the contingency management treatment for smoking cessation differ from other treatments?

Contingency management for smoking cessation is unique because it uses incentives, like money or prizes, to encourage people to quit smoking. This approach is different from traditional methods as it directly rewards individuals for maintaining abstinence, which can increase motivation and participation.123910

Research Team

BT

Benjamin Toll, PhD

Principal Investigator

Medical University of South Carolina

Eligibility Criteria

This trial is for adult smokers diagnosed with or suspected to have operable cancer, who are about to undergo surgery. Participants must smoke at least one cigarette daily and speak English. Those using alternative nicotine products, pregnant women, or individuals with unstable psychiatric/medical conditions cannot join.

Inclusion Criteria

I am 18 years old or older.
I have been diagnosed with or suspected to have a type of cancer that can be operated on.
You smoke at least one cigarette every day.

Exclusion Criteria

You use electronic cigarettes, snus, or other similar products that deliver nicotine.
I do not speak English.
I do not have any severe mental health issues like thoughts of suicide, psychosis, or dementia.
See 1 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive standard smoking cessation therapy including counseling and the nicotine patch. Half of the participants receive a novel smoking cessation treatment.

6 weeks

Follow-up

Participants are monitored for smoking abstinence through self-report, Carbon Monoxide Breath Monitoring, and Anabasine testing.

6 months

Treatment Details

Interventions

  • Contingency Management (Behavioural Intervention)
Trial OverviewThe study tests a new smoking cessation treatment against standard care in cancer patients facing surgery. Half will receive the novel treatment plus counseling and nicotine patches; the other half will get only the standard therapy.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Contingency ManagementExperimental Treatment1 Intervention
Group II: Standard CareActive Control1 Intervention

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Medical University of South CarolinaCharleston, SC
Loading ...

Who Is Running the Clinical Trial?

Medical University of South Carolina

Lead Sponsor

Trials
994
Recruited
7,408,000+
Dr. Erik Summers profile image

Dr. Erik Summers

Medical University of South Carolina

Chief Medical Officer

MD from University of Alabama at Birmingham

Dr. Patrick J. Cawley profile image

Dr. Patrick J. Cawley

Medical University of South Carolina

Chief Executive Officer

MD, MBA

National Cancer Institute (NCI)

Collaborator

Trials
14080
Recruited
41,180,000+
Dr. Douglas R. Lowy profile image

Dr. Douglas R. Lowy

National Cancer Institute (NCI)

Chief Executive Officer since 2023

MD from New York University School of Medicine

Dr. Monica Bertagnolli profile image

Dr. Monica Bertagnolli

National Cancer Institute (NCI)

Chief Medical Officer since 2022

MD from Harvard Medical School

Findings from Research

Monetary incentives based on group performance significantly promoted brief abstinence from cigarette smoking, with 53% of participants submitting negative breath carbon monoxide samples when vouchers were contingent on team performance.
Both individual and team-based incentives were effective in increasing abstinence rates compared to a no-voucher condition, suggesting that interdependent contingencies can be a cost-effective strategy for smoking cessation programs.
Investigating group contingencies to promote brief abstinence from cigarette smoking.Meredith, SE., Dallery, J.[2023]
In a study involving 146 participants from a smoking cessation program, those who received financial incentives for abstinence (contingency management) had significantly higher smoking abstinence rates compared to those who received usual care, with rates of 49.3% versus 25.4% at 4 weeks post-quit date.
The financial incentives, averaging $63.40 earned by participants, proved effective in encouraging abstinence, particularly among socioeconomically disadvantaged individuals, suggesting that such strategies could enhance smoking cessation efforts in similar populations.
Financial incentives for abstinence among socioeconomically disadvantaged individuals in smoking cessation treatment.Kendzor, DE., Businelle, MS., Poonawalla, IB., et al.[2022]
In a study involving 75 socioeconomically disadvantaged adults, those who placed greater importance on earning financial incentives for smoking cessation were significantly more likely to achieve continuous abstinence during the four-week intervention (OR = 3.95) and up to 12 weeks post-quit day (OR = 4.71).
The results indicate that an individual's perception of the importance of financial incentives can predict their success in quitting smoking, suggesting that tailoring incentive programs to enhance perceived value may improve outcomes.
Greater perceived importance of earning abstinence-contingent incentives is associated with smoking cessation among socioeconomically disadvantaged adults.Alexander, AC., Hébert, ET., Businelle, MS., et al.[2022]

References

Prize contingency management for smoking cessation: a randomized trial. [2022]
Incentives in smoking cessation: status of the field and implications for research and practice with pregnant smokers. [2006]
The relative contribution of economic valence to contingency management efficacy: a pilot study. [2021]
Investigating group contingencies to promote brief abstinence from cigarette smoking. [2023]
Financial incentives for abstinence among socioeconomically disadvantaged individuals in smoking cessation treatment. [2022]
Greater perceived importance of earning abstinence-contingent incentives is associated with smoking cessation among socioeconomically disadvantaged adults. [2022]
Internet-based contingency management to promote smoking cessation: a randomized controlled study. [2022]
Internet-based self-tailored deposit contracts to promote smoking reduction and abstinence. [2018]
Randomized trial of contingent prizes versus vouchers in cocaine-using methadone patients. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Vouchers versus prizes: contingency management treatment of substance abusers in community settings. [2016]